Univest
Univest
  • Markets

Lactose (India) (LACTOSE): Lactose India Share Price Falls 11.50% to Rs 92.35 as Micro Cap Stock Declines

  • November 16, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Lactose India Share Price
Lactose (India) (LACTOSE) share price fell to Rs 92.35 today, down 11.5% from the previous close. Market cap was Rs 131.37 crore.

Lactose India Share Price fell 11.50% on 16 November 2026, with the stock trading at Rs 92.35 against a previous close of Rs 104.35 as of 16 November 2026 at 11:38:00 AM IST. The decline of Rs 12.00 leaves the Micro Cap Pharmaceuticals & Drugs company with a market capitalisation of Rs 131.37 crore, and it has made Lactose India stock news for market watchers today.

This Lactose India Share Price fall is the event Univest is tracking in today’s market update. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. What readers can verify is the price action and the company’s financial ratios, which show a P/E ratio of 18.96, a P/B ratio of 2.17, ROE of 10.98% and ROCE of 11.35%.

Anyone following Lactose India Share Price Today should keep an eye on the day range of Rs 89.90 to Rs 102.15 and on how the valuation compares with Pharmaceuticals & Drugs peers. Both points are covered in the sections below, along with sector benchmarks, company context and answers to common questions.

Table of Contents

Toggle
  • Lactose (India) (LACTOSE) Share Price Today: Price Action Analysis
  • Lactose (India) (LACTOSE) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Lactose India
  • About Lactose India
  • Track Lactose India Share Price on Univest
  • Frequently Asked Questions
    • Why is Lactose India share price falling today?
    • What is the Lactose India share price today?
    • What is the market capitalisation of Lactose India?
    • What is the P/E ratio of Lactose India?
    • What are the ROE and ROCE of Lactose India?
    • What is the book value of Lactose India?
    • Does Lactose India pay a dividend?
    • How does Lactose India compare with its peers?
    • Which sector does Lactose India belong to?

Lactose (India) (LACTOSE) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 92.35
Previous Close Rs 104.35
Today's Move -Rs 12.00 (-11.5%)
Open Rs 100.35
High Rs 102.15
Low Rs 89.9
Market Capitalisation Rs 131.37 crore
Market Cap Category Micro Cap

Lactose India Share Price Today stands at Rs 92.35, down Rs 12.00 or 11.50% from the previous close of Rs 104.35. The stock opened at Rs 100.35, touched a high of Rs 102.15 and a low of Rs 89.90 as of 16 November 2026 at 11:38:00 AM IST.

The opening price of Rs 100.35 was already Rs 4.00 below the previous close. From there, the Lactose India Share Price first reached the day high of Rs 102.15, which is Rs 1.80 above the opening level, and then moved lower to the intraday low of Rs 89.90. The range between the high and the low is Rs 12.25, and at Rs 92.35 the stock is Rs 2.45 above the low and Rs 8.00 below its opening price.

The Lactose India share price fall comes for a company that Univest classifies as Micro Cap, with a market capitalisation of Rs 131.37 crore. Market capitalisation indicates company size rather than business quality, so the Lactose India stock performance today needs to be read alongside the financial ratios.

Readers checking the Lactose India Share Price Update should note the size of the move, the intraday range and the previous close of Rs 104.35 as the starting point. Those facts frame the fundamental picture covered next.

Lactose (India) (LACTOSE) Fundamental Analysis

Metric Value
Market Capitalisation Rs 131.37 crore
P/E Ratio 18.96x
P/B Ratio 2.17x
ROE 10.98%
ROCE 11.35%
EPS Rs 5.5
Book Value Per Share Rs 48.16
Dividend Yield 0%

Lactose (India) (LACTOSE) fundamental metrics show P/E 18.96x, P/B 2.17x, ROE 10.98%, ROCE 11.35%. These figures provide context only and are not a buy or sell signal.

Lactose (India) has a market capitalisation of Rs 131.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.96x, P/B at 2.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.98% and ROCE of 11.35%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.5, book value per share of Rs 48.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 18.96x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 2.17x
Benchmark Median P/B 2.9x
Benchmark Average P/B 3.43x
Company ROE 10.98%
Benchmark Median ROE 10.98%
Benchmark Average ROE 4.7%
Company ROCE 11.35%
Benchmark Median ROCE 12.63%
Benchmark Average ROCE 3.14%
Company Market Capitalisation Rs 131.37 crore
Benchmark Median Market Cap Rs 698.04 crore
Benchmark Average Market Cap Rs 14,540.61 crore

Lactose (India) (LACTOSE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Lactose (India) (LACTOSE) has a P/E ratio of 18.96x, which is below the benchmark median of 30.93x, a difference of -38.7%. On its own, the P/E gap is a valuation reference point, not a trading call.

Lactose (India) (LACTOSE) has a ROE of 10.98%, which is equal to the benchmark median of 10.98%, a difference of 0%. Lactose (India) (LACTOSE) has a ROCE of 11.35%, which is below the benchmark median of 12.63%, a difference of -10.13%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Lactose (India) (LACTOSE) has a P/E ratio of 18.96x compared with the displayed peer median of 83.49x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.98% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.35% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lactose (India) (LACTOSE) has a market capitalisation of Rs 131.37 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Lactose India

  • Price action: Lactose India Share Price fell 11.50% to Rs 92.35 from a previous close of Rs 104.35.
  • Day range: the stock moved between Rs 89.90 and Rs 102.15 as of 16 November 2026 at 11:38:00 AM IST.
  • Valuation: a P/E of 18.96 and a P/B of 2.17 sit below the benchmark medians of 30.93 and 2.90.
  • Returns: ROE of 10.98% matches the benchmark median of 10.98%, while ROCE of 11.35% sits below the median of 12.63%.
  • Size: a market capitalisation of Rs 131.37 crore keeps the company in the Micro Cap category, below the industry median of Rs 698.04 crore.

About Lactose India

Lactose India Share Price relates to Lactose (India), which trades under the symbol LACTOSE and operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. This company overview places it among the smaller names of its same-industry benchmark of 205 companies, with a market capitalisation of Rs 131.37 crore against a benchmark median of Rs 698.04 crore. Univest groups it with Pharmaceuticals & Drugs companies such as Sun Pharmaceutical Industries and Zydus Lifesciences for benchmark purposes.

Track Lactose India Share Price on Univest

Use Lactose (India) (LACTOSE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Users can follow the Lactose India Share Price Live on Univest, along with fundamental ratios, 52-week levels and market insights in one place. The Univest stock page brings together the latest price, valuation multiples, return ratios and peer context, so readers can check the Lactose India Share Price Today and the company’s numbers without switching between sources.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Lactose India share price falling today?

Ans. Lactose India Share Price fell 11.50% to Rs 92.35 from a previous close of Rs 104.35. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Its current market capitalisation is Rs 131.37 crore.

What is the Lactose India share price today?

Ans. Lactose India share price is Rs 92.35 as of 16 November 2026 at 11:38:00 AM IST. The stock opened at Rs 100.35, touched an intraday low of Rs 89.90 and is down Rs 12.00 from the previous close today.

What is the market capitalisation of Lactose India?

Ans. Lactose India Share Price reflects a market capitalisation of Rs 131.37 crore, which places the company in the Micro Cap category on Univest. The same-industry benchmark median is Rs 698.04 crore, so the company is smaller than the median.

What is the P/E ratio of Lactose India?

Ans. The P/E ratio behind the Lactose India Share Price is 18.96, against a same-industry benchmark median of 30.93 and an average of 52.22. The EPS is Rs 5.50, which shows the earnings attributable to each share of the company.

What are the ROE and ROCE of Lactose India?

Ans. Lactose India reports ROE of 10.98% and ROCE of 11.35% in the latest figures. The ROE matches the same-industry benchmark median of 10.98%, while the ROCE sits below the median of 12.63%, adding context to the Lactose India Share Price.

What is the book value of Lactose India?

Ans. Book value per share is Rs 48.16 and the P/B ratio is 2.17. Book value shows the accounting net worth behind each share, while P/B relates the current price directly to that figure. The same-industry benchmark P/B median is 2.90.

Does Lactose India pay a dividend?

Ans. Dividend yield for Lactose India is 0% in the latest figures. Dividend yield shows the historical payout relative to the current price and does not promise a future payout, so read it alongside the Lactose India Share Price.

How does Lactose India compare with its peers?

Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences, Lactose India has a lower P/E and P/B than every peer, with ROE and ROCE also below all five and a much smaller market capitalisation.

Which sector does Lactose India belong to?

Ans. Lactose India belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Univest benchmarks it against 205 companies in its industry, where its P/E of 18.96 sits below the median of 30.93 and the average of 52.22.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply